Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Charge states and lattice sites of dilute implanted Sn in ZnO.

Mølholt TE, Gunnlaugsson H, Johnston K, Mantovan R, Röder J, Adoons V, Gerami A, Masenda H, Matveyev Y, Ncube M, Unzueta I, Bharuth-Ram K, Gislason H, Krastev P, Langouche G, Naidoo D, Olafsson S, Zenkevich A.

J Phys Condens Matter. 2017 Feb 6. doi: 10.1088/1361-648X/aa5e95. [Epub ahead of print]

PMID:
28165333
2.

A sequence variant associating with educational attainment also affects childhood cognition.

Gunnarsson B, Jónsdóttir GA, Björnsdóttir G, Konte B, Sulem P, Kristmundsdóttir S, Kehr B, Gústafsson Ó, Helgason H, Iordache PD, Ólafsson S, Frigge ML, Þorleifsson G, Arnarsdóttir S, Stefánsdóttir B, Giegling I, Djurovic S, Sundet KS, Espeseth T, Melle I, Hartmann AM, Thorsteinsdottir U, Kong A, Guðbjartsson DF, Ettinger U, Andreassen OA, Dan Rujescu, Halldórsson JG, Stefánsson H, Halldórsson BV, Stefánsson K.

Sci Rep. 2016 Nov 4;6:36189. doi: 10.1038/srep36189.

3.

[Liver transplantation in Iceland: a retrospective study of indications and results].

Eggertsdóttir Claessen LÓ, Björnsson ES, Bergmann ÓM, Ólafsson S.

Laeknabladid. 2016 Jan;102(1):19-24. doi: 10.17992/lbl.2016.01.60. Icelandic.

PMID:
26734719
4.

A prospective study on the causes of notably raised alanine aminotransferase (ALT).

Björnsson HK, Olafsson S, Bergmann OM, Björnsson ES.

Scand J Gastroenterol. 2016;51(5):594-600. doi: 10.3109/00365521.2015.1121516.

PMID:
26653080
5.

An empirical analysis of the demand for sleep: Evidence from the American Time Use Survey.

Ásgeirsdóttir TL, Ólafsson SP.

Econ Hum Biol. 2015 Dec;19:265-74.

PMID:
26603429
6.

Strategies to manage hepatitis C virus infection disease burden - volume 3.

Alfaleh FZ, Nugrahini N, Matičič M, Tolmane I, Alzaabi M, Hajarizadeh B, Valantinas J, Kim DY, Hunyady B, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alavian SM, Alawadhi S, Al-Dabal L, Aldins P, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Goldis A, Gottfredsson M, Gregorcic S, Gunter J, Hamid S, Han KH, Hasan I, Hashim A, Horvath G, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim YS, Koutoubi Z, Lesmana LA, Liakina V, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sharara AI, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Ud Din M, Umar M, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Blach S.

J Viral Hepat. 2015 Dec;22 Suppl 4:42-65. doi: 10.1111/jvh.12474.

PMID:
26513447
7.

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.

Sibley A, Han KH, Abourached A, Lesmana LA, Makara M, Jafri W, Salupere R, Assiri AM, Goldis A, Abaalkhail F, Abbas Z, Abdou A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alavian SM, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Gottfredsson M, Gregorcic S, Gunter J, Hajarizadeh B, Hamid S, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jeruma A, Jonasson JG, Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Liakina V, Lim YS, Löve A, Maimets M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Sharara AI, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Schmelzer JD.

J Viral Hepat. 2015 Dec;22 Suppl 4:21-41. doi: 10.1111/jvh.12476.

PMID:
26513446
8.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.

Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, Gheorghe L, El Hassan ES, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Goldis A, Gottfredsson M, Gregorcic S, Hajarizadeh B, Han KH, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Lesmana LA, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Gunter J.

J Viral Hepat. 2015 Dec;22 Suppl 4:4-20. doi: 10.1111/jvh.12475.

PMID:
26513445
9.

Muon detection studied by pulse-height energy analysis: Novel converter arrangements.

Holmlid L, Olafsson S.

Rev Sci Instrum. 2015 Aug;86(8):083306. doi: 10.1063/1.4928109.

PMID:
26329180
10.

[Revolution of hepatitis C antiviral therapy: when will Icelanders gain access to the new drugs?[Editorial]].

Ólafsson S.

Laeknabladid. 2015 Jun;101(6):295. Icelandic. No abstract available.

PMID:
26158532
11.

Secondary sclerosing cholangitis in patients with drug-induced liver injury.

Gudnason HO, Björnsson HK, Gardarsdottir M, Thorisson HM, Olafsson S, Bergmann OM, Björnsson ES.

Dig Liver Dis. 2015 Jun;47(6):502-7. doi: 10.1016/j.dld.2015.03.002.

PMID:
25840876
12.

Large-scale whole-genome sequencing of the Icelandic population.

Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, Besenbacher S, Magnusson G, Halldorsson BV, Hjartarson E, Sigurdsson GT, Stacey SN, Frigge ML, Holm H, Saemundsdottir J, Helgadottir HT, Johannsdottir H, Sigfusson G, Thorgeirsson G, Sverrisson JT, Gretarsdottir S, Walters GB, Rafnar T, Thjodleifsson B, Bjornsson ES, Olafsson S, Thorarinsdottir H, Steingrimsdottir T, Gudmundsdottir TS, Theodors A, Jonasson JG, Sigurdsson A, Bjornsdottir G, Jonsson JJ, Thorarensen O, Ludvigsson P, Gudbjartsson H, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Arnar DO, Magnusson OT, Kong A, Masson G, Thorsteinsdottir U, Helgason A, Sulem P, Stefansson K.

Nat Genet. 2015 May;47(5):435-44. doi: 10.1038/ng.3247.

PMID:
25807286
13.

Risk of drug-induced liver injury from tumor necrosis factor antagonists.

Björnsson ES, Gunnarsson BI, Gröndal G, Jonasson JG, Einarsdottir R, Ludviksson BR, Gudbjörnsson B, Olafsson S.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):602-8. doi: 10.1016/j.cgh.2014.07.062.

PMID:
25131534
14.

Alcohol consumption and liver cirrhosis mortality after lifting ban on beer sales in country with state alcohol monopoly.

Tyrfingsson T, Olafsson S, Bjornsson ES, Rafnsson V.

Eur J Public Health. 2015 Aug;25(4):729-31. doi: 10.1093/eurpub/cku127.

PMID:
25085471
15.

Low adherence to Helicobacter pylori testing in hospitalized patients with bleeding peptic ulcer disease.

Kim JJ, Lee JS, Olafsson S, Laine L.

Helicobacter. 2014 Apr;19(2):98-104. doi: 10.1111/hel.12114.

PMID:
24617668
16.

Magnetic self-organized atomic laminate from first principles and thin film synthesis.

Ingason AS, Mockute A, Dahlqvist M, Magnus F, Olafsson S, Arnalds UB, Alling B, Abrikosov IA, Hjörvarsson B, Persson PO, Rosen J.

Phys Rev Lett. 2013 May 10;110(19):195502.

PMID:
23705717
17.

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S.

Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006.

PMID:
23419359
18.

Differences and similarities in the etiology and the incidence of cirrhosis in the Nordic countries.

Olafsson S, Björnsson ES.

Scand J Gastroenterol. 2013 Apr;48(4):509-10. doi: 10.3109/00365521.2012.749512. No abstract available.

PMID:
23362859
19.

Bleeding Meckel's diverticulum diagnosed and treated by double-balloon enteroscopy.

Olafsson S, Yang JT, Jackson CS, Barakat M, Lo S.

Avicenna J Med. 2012 Apr;2(2):48-50. doi: 10.4103/2231-0770.99166.

20.

Hepatitis E masquerading as drug-induced liver injury.

Chen EY, Baum K, Collins W, Löve A, Merz M, Olafsson S, Björnsson ES, Lee WM.

Hepatology. 2012 Dec;56(6):2420-3. doi: 10.1002/hep.26158.

PMID:
23175167
Items per page

Supplemental Content

Loading ...
Support Center